Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.

Ohm DT, Fought AJ, Rademaker A, Kim G, Sridhar J, Coventry C, Gefen T, Weintraub S, Bigio E, Mesulam MM, Rogalski E, Geula C.

Brain Pathol. 2019 Aug 25. doi: 10.1111/bpa.12783. [Epub ahead of print]

PMID:
31446630
2.

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity.

Garrido G, Schrand B, Rabasa A, Levay A, D'Eramo F, Berezhnoy A, Modi S, Gefen T, Marijt K, Doorduijn E, Dudeja V, van Hall T, Gilboa E.

Nat Commun. 2019 Aug 21;10(1):3773. doi: 10.1038/s41467-019-11728-2.

3.

FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.

Mao Q, Zheng X, Gefen T, Rogalski E, Spencer CL, Rademakers R, Fought AJ, Kohler M, Weintraub S, Xia H, Mesulam MM, Bigio EH.

J Neuropathol Exp Neurol. 2019 Sep 1;78(9):844-853. doi: 10.1093/jnen/nlz059.

PMID:
31361008
4.

Activated Microglia in Cortical White Matter Across Cognitive Aging Trajectories.

Gefen T, Kim G, Bolbolan K, Geoly A, Ohm D, Oboudiyat C, Shahidehpour R, Rademaker A, Weintraub S, Bigio EH, Mesulam MM, Rogalski E, Geula C.

Front Aging Neurosci. 2019 May 14;11:94. doi: 10.3389/fnagi.2019.00094. eCollection 2019.

5.

Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes.

Nishihira Y, Gefen T, Mao Q, Appin C, Kohler M, Walker J, Rademakers R, Rademaker A, Rogalski E, Weintraub S, Geula C, Mesulam MM, Bigio EH.

Acta Neuropathol. 2019 Jul;138(1):167-169. doi: 10.1007/s00401-019-02024-w. Epub 2019 May 7. No abstract available.

PMID:
31065833
6.

Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology.

Mesulam MM, Lalehzari N, Rahmani F, Ohm D, Shahidehpour R, Kim G, Gefen T, Weintraub S, Bigio E, Geula C.

Neurology. 2019 Apr 2;92(14):e1580-e1588. doi: 10.1212/WNL.0000000000007247. Epub 2019 Mar 6.

PMID:
30842294
7.

Limits on Spectral Resolution Measurements by Quantum Probes.

Rotem A, Gefen T, Oviedo-Casado S, Prior J, Schmitt S, Burak Y, McGuiness L, Jelezko F, Retzker A.

Phys Rev Lett. 2019 Feb 15;122(6):060503. doi: 10.1103/PhysRevLett.122.060503.

PMID:
30822046
8.

Morphology and Distribution of TDP-43 Pre-inclusions in Primary Progressive Aphasia.

Kim G, Bolbolan K, Shahidehpour R, Jamshidi P, Gefen T, Ayala IA, Weintraub S, Bigio EH, Mesulam MM, Geula C.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):229-237. doi: 10.1093/jnen/nlz005.

PMID:
30753613
9.

Word comprehension in temporal cortex and Wernicke area: A PPA perspective.

Mesulam MM, Rader BM, Sridhar J, Nelson MJ, Hyun J, Rademaker A, Geula C, Bigio EH, Thompson CK, Gefen TD, Weintraub S, Rogalski EJ.

Neurology. 2019 Jan 15;92(3):e224-e233. doi: 10.1212/WNL.0000000000006788. Epub 2018 Dec 21.

PMID:
30578374
10.

What Came First: The Microbiota or the Tr(egg) Cells?

Gefen T, Geva-Zatorsky N.

Immunity. 2018 Jun 19;48(6):1072-1074. doi: 10.1016/j.immuni.2018.06.005.

11.

Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia.

Ohm DT, Kim G, Gefen T, Rademaker A, Weintraub S, Bigio EH, Mesulam MM, Rogalski E, Geula C.

Neuropathol Appl Neurobiol. 2019 Apr;45(3):216-229. doi: 10.1111/nan.12494. Epub 2018 May 17.

PMID:
29679378
12.

Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa.

Kim G, Bolbolan K, Gefen T, Weintraub S, Bigio EH, Rogalski E, Mesulam MM, Geula C.

Ann Neurol. 2018 Jun;83(6):1096-1104. doi: 10.1002/ana.25240. Epub 2018 May 24.

13.

Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition.

Puplampu-Dove Y, Gefen T, Rajagopalan A, Muheramagic D, Schrand B, Gilboa E.

Oncoimmunology. 2018 Feb 15;7(4):e1349588. doi: 10.1080/2162402X.2017.1349588. eCollection 2018.

14.

Combined Pathologies in FTLD-TDP Types A and C.

Gefen T, Ahmadian SS, Mao Q, Kim G, Seckin M, Bonakdarpour B, Ramos EM, Coppola G, Rademakers R, Rogalski E, Rademaker A, Weintraub S, Mesulam MM, Geula C, Bigio EH.

J Neuropathol Exp Neurol. 2018 May 1;77(5):405-412. doi: 10.1093/jnen/nly018.

15.

Cognitive trajectories and spectrum of neuropathology in SuperAgers: The first 10 cases.

Rogalski E, Gefen T, Mao Q, Connelly M, Weintraub S, Geula C, Bigio EH, Mesulam MM.

Hippocampus. 2019 May;29(5):458-467. doi: 10.1002/hipo.22828. Epub 2018 Feb 5.

PMID:
29341318
16.

Asymmetric TDP pathology in primary progressive aphasia with right hemisphere language dominance.

Kim G, Vahedi S, Gefen T, Weintraub S, Bigio EH, Mesulam MM, Geula C.

Neurology. 2018 Jan 30;90(5):e396-e403. doi: 10.1212/WNL.0000000000004891. Epub 2018 Jan 5.

17.

Von Economo neurons of the anterior cingulate across the lifespan and in Alzheimer's disease.

Gefen T, Papastefan ST, Rezvanian A, Bigio EH, Weintraub S, Rogalski E, Mesulam MM, Geula C.

Cortex. 2018 Feb;99:69-77. doi: 10.1016/j.cortex.2017.10.015. Epub 2017 Nov 8.

18.

A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice.

Gefen T, Castro I, Muharemagic D, Puplampu-Dove Y, Patel S, Gilboa E.

Mol Ther. 2017 Oct 4;25(10):2280-2288. doi: 10.1016/j.ymthe.2017.06.023. Epub 2017 Aug 8.

19.

Submillihertz magnetic spectroscopy performed with a nanoscale quantum sensor.

Schmitt S, Gefen T, Stürner FM, Unden T, Wolff G, Müller C, Scheuer J, Naydenov B, Markham M, Pezzagna S, Meijer J, Schwarz I, Plenio M, Retzker A, McGuinness LP, Jelezko F.

Science. 2017 May 26;356(6340):832-837. doi: 10.1126/science.aam5532.

PMID:
28546208
20.

Variations in Acetylcholinesterase Activity within Human Cortical Pyramidal Neurons Across Age and Cognitive Trajectories.

Janeczek M, Gefen T, Samimi M, Kim G, Weintraub S, Bigio E, Rogalski E, Mesulam MM, Geula C.

Cereb Cortex. 2018 Apr 1;28(4):1329-1337. doi: 10.1093/cercor/bhx047.

21.

Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.

Oboudiyat C, Gefen T, Varelas E, Weintraub S, Rogalski E, Bigio EH, Mesulam MM.

Alzheimers Dement. 2017 May;13(5):598-601. doi: 10.1016/j.jalz.2017.01.006. Epub 2017 Feb 11.

22.

Formation of multimeric antibodies for self-delivery of active monomers.

Dekel Y, Machluf Y, Gefen T, Eidelshtein G, Kotlyar A, Bram Y, Shahar E, Reslane F, Aizenshtein E, Pitcovski J.

Drug Deliv. 2017 Nov;24(1):199-208. doi: 10.1080/10717544.2016.1242179.

PMID:
28156181
23.

Quantum Error-Correction-Enhanced Magnetometer Overcoming the Limit Imposed by Relaxation.

Herrera-Martí DA, Gefen T, Aharonov D, Katz N, Retzker A.

Phys Rev Lett. 2015 Nov 13;115(20):200501. doi: 10.1103/PhysRevLett.115.200501. Epub 2015 Nov 9.

PMID:
26613424
24.

Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity.

Gefen T, Peterson M, Papastefan ST, Martersteck A, Whitney K, Rademaker A, Bigio EH, Weintraub S, Rogalski E, Mesulam MM, Geula C.

J Neurosci. 2015 Jan 28;35(4):1781-91. doi: 10.1523/JNEUROSCI.2998-14.2015.

25.

Longitudinal neuropsychological performance of cognitive SuperAgers.

Gefen T, Shaw E, Whitney K, Martersteck A, Stratton J, Rademaker A, Weintraub S, Mesulam MM, Rogalski E.

J Am Geriatr Soc. 2014 Aug;62(8):1598-600. doi: 10.1111/jgs.12967. No abstract available.

26.

The effect of haptens on protein-carrier immunogenicity.

Gefen T, Vaya J, Khatib S, Rapoport I, Lupo M, Barnea E, Admon A, Heller ED, Aizenshtein E, Pitcovski J.

Immunology. 2015 Jan;144(1):116-26. doi: 10.1111/imm.12356.

27.

Naming vs knowing faces in primary progressive aphasia: a tale of 2 hemispheres.

Gefen T, Wieneke C, Martersteck A, Whitney K, Weintraub S, Mesulam MM, Rogalski E.

Neurology. 2013 Aug 13;81(7):658-64. doi: 10.1212/WNL.0b013e3182a08f83.

28.

The impact of PEGylation on protein immunogenicity.

Gefen T, Vaya J, Khatib S, Harkevich N, Artoul F, Heller ED, Pitcovski J, Aizenshtein E.

Int Immunopharmacol. 2013 Feb;15(2):254-9. doi: 10.1016/j.intimp.2012.12.012. Epub 2013 Jan 7.

PMID:
23306102
29.

Youthful memory capacity in old brains: anatomic and genetic clues from the Northwestern SuperAging Project.

Rogalski EJ, Gefen T, Shi J, Samimi M, Bigio E, Weintraub S, Geula C, Mesulam MM.

J Cogn Neurosci. 2013 Jan;25(1):29-36. doi: 10.1162/jocn_a_00300.

30.

Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.

Gefen T, Gasho K, Rademaker A, Lalehzari M, Weintraub S, Rogalski E, Wieneke C, Bigio E, Geula C, Mesulam MM.

Brain. 2012 May;135(Pt 5):1554-65. doi: 10.1093/brain/aws076. Epub 2012 Apr 19.

31.

Coated cross-species antibodies by mannosamine-biotin adduct confer protection against snake venom without eliciting humoral immune response.

Gefen T, Pitcovski J, Vaya J, Khatib S, Krispel S, Heller ED, Gaberman E, Gorodetsky R, Aizenshtein E.

Vaccine. 2010 Nov 29;28(51):8197-202. doi: 10.1016/j.vaccine.2010.09.032. Epub 2010 Sep 25.

PMID:
20875497
32.

Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction.

Vaya J, Aizenshtein E, Khatib S, Gefen T, Fassler M, Musa R, Krispel S, Pitcovski J.

Vaccine. 2009 Nov 16;27(49):6869-76. doi: 10.1016/j.vaccine.2009.09.010. Epub 2009 Sep 16.

PMID:
19765399
33.

The effect of insoles on the incidence and severity of low back pain among workers whose job involves long-distance walking.

Shabat S, Gefen T, Nyska M, Folman Y, Gepstein R.

Eur Spine J. 2005 Aug;14(6):546-50. Epub 2005 Jan 25.

Supplemental Content

Support Center